Suzano / Kimberly-Clark JV Merger Inquiry

Why It Matters

The outcome will shape competition for tissue and paper products in the UK, affecting pricing and supply for retailers, and signals regulatory scrutiny of cross‑border joint ventures in essential consumer goods.

Key Takeaways

• CMA opened Phase 1 inquiry on March 27, 2026.
• Suzano‑Kimberly‑Clark JV under competition review in UK.
• Comments accepted until May 28, 2026 deadline.
• Pre‑notification information already submitted to CMA.
• Potential impact on UK tissue and paper market competition.

Pulse Analysis

The joint venture between Suzano, the world’s second‑largest pulp producer, and Kimberly‑Clark, a leading maker of consumer tissue products, aims to combine Suzano’s raw material strength with Kimberly‑Clark’s brand portfolio across Europe and North America. By pooling resources, the partnership seeks to streamline supply chains, accelerate innovation in sustainable packaging, and capture a larger share of the high‑margin tissue market. Analysts estimate the JV could generate annual revenues exceeding €5 billion (about $5.4 billion), positioning it as a formidable competitor to established players such as Procter & Gamble and Essity.

The UK Competition and Markets Authority’s Phase 1 inquiry, launched on 27 March 2026, is the first formal step in assessing whether the Suzano‑Kimberly‑Clark JV would substantially lessen competition in the British market. The CMA’s invitation‑to‑comment window runs until 28 May 2026, allowing competitors, consumer groups, and other stakeholders to submit written representations. During this stage, the regulator reviews the parties’ pre‑notification documents, market share data, and potential efficiencies. A swift decision is possible, but the statutory deadline may be extended if complex issues arise.

Should the CMA conclude that the joint venture harms competition, it could impose remedies ranging from divestitures of specific product lines to behavioral commitments that preserve market access for rivals. Conversely, approval with conditions would signal confidence that the efficiencies outweigh anti‑competitive risks, encouraging similar cross‑border collaborations in the pulp‑and‑paper sector. The inquiry also reflects a broader trend of heightened scrutiny on large‑scale consolidations in essential consumer goods, where regulators balance cost‑saving benefits against the need to protect price stability and consumer choice.